Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis

European Respiratory Journal

Volumn 35, Issue 3, 2010, Pages 692-694

  Allix Beguec C ^a,e,f   Fauville Dufaux, M ^a   Stoffels, K ^a   Ommeslag, D ^b   Walravens, K ^c   Saegerman, C ^d   Supply, P ^e,f  

^a PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^b AZ Saint Lucas   (Belgium)

^c Centre d'Etude et de Recherches Vétérinaires et Agrochimiques   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e INSERM   (France)

^f INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

BACTERIUM CONTAMINATION; BACTERIUM IDENTIFICATION; DRUG SENSITIVITY; LETTER; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; ZOONOSIS;

AGED; AGRICULTURAL WORKERS' DISEASES; ANIMALS; ANTITUBERCULAR AGENTS; BELGIUM; CATTLE; DAIRYING; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FATAL OUTCOME; FEMALE; GENOTYPE; HUMANS; MINISATELLITE REPEATS; MYCOBACTERIUM BOVIS; TUBERCULOSIS, BOVINE; TUBERCULOSIS, PULMONARY;

EID: 77951150883     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00137309     Document Type: Letter

References (11)

1. Evans JT, Smith EG, Banerjee A, et al. Cluster of human tuberculosis caused by Mycobacterium bovis: evidence for person-to-person transmission in the UK. Lancet 2007; 369: 1270-1276. (Pubitemid 46552049)
2. LoBue PA, Moser KS. Treatment of Mycobacterium bovis infected tuberculosis patients: San Diego County, California, United States, 1994-2003. Int J Tuberc Lung Dis 2005; 9: 333-338.
3. Rivero A, Marquez M, Santos J, et al. High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B. Clin Infect Dis 2001; 32: 159-161. (Pubitemid 32150963)
4. O'Donohue WJ Jr, Bedi S, Bittner MJ, et al. Short-course chemotherapy for pulmonary infection due to Mycobacterium bovis. Arch Intern Med 1985; 145: 703-705. (Pubitemid 15077938)
5. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-662.
6. Brosch R, Gordon SV, Marmiesse M, et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci USA 2002; 99: 3684-3689. (Pubitemid 34252166)
7. Allix C, Walravens K, Saegerman C, et al. Evaluation of the epidemiological relevance of variable-number tandem-repeat genotyping of Mycobacterium bovis and comparison of the method with IS6110 restriction fragment length polymorphism analysis and spoligotyping. J Clin Microbiol 2006; 44: 1951-1962. (Pubitemid 43902140)
8. Supply P, Allix C, Lesjean S, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 2006; 44: 4498-4510. (Pubitemid 44937085)
9. Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35: 907-914. (Pubitemid 27146535)
10. van Embden JD, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-409. (Pubitemid 23028649)
11. Allix-Beguec C, Harmsen D, Weniger T, et al. Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2008; 46: 2692-2699.